Neuropsicofarmacología - GIC 21/128
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadoras/es de Harvard Medical School (8)
2023
-
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 927-936
2022
-
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Annals of the Rheumatic Diseases, Vol. 81, Núm. 8, pp. 1143-1150
2021
-
European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781
2020
-
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
Annals of the Rheumatic Diseases, Vol. 79, Núm. 10, pp. 1333-1339
2019
-
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159
2017
2012
-
Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment
ARTHRITIS AND RHEUMATISM
2011
-
The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: Control by depolarization and lithium
Bipolar Disorders, Vol. 13, Núm. 5-6, pp. 474-485